Atinumab (anti-NOGO) (C007B-552918)

Atinumab (anti-NOGO) is a monoclonal antibody targeting reticulon-4. It has immunomodulating activity and can be used for the research of spinal cord injury (SCI).Purity>95% (SDS-PAGE&SEC)Endotoxin Level< 1.0EU/mg

Specification: ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot

Related Documents: https://ald-pub-files.oss-cn-shanghai.aliyuncs.com/aladdinsci/pdp/sds/1/AB183417-SCI_3b034d948721e7240b2729ac4a2f32ec.pdf

UPC:

51201569

Condition:

New

Weight:

0.07 Ounces

HazmatClass:

No

Quantity:

1

Unit of Measurement:

EA

WeightUOM:

LB

MPN:

Ab183417-5mg

CAS:

1226761-65-4

Product Size:

5mg